Goldman Sachs Group Inc Novo Nordisk A S Transaction History

Goldman Sachs Group Inc

$613 Billion
Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Goldman Sachs Group Inc holds 4,247,154 shares of NVO stock, worth $374 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

4,247,154

Previous 4,509,803 5.82%

Holding current value

$374 Million

Previous $537 Million 31.96%

% of portfolio

0.06%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$85.0 - $120.04 $22.3 Million - $31.5 Million	-262,649 Reduced 5.82%	4,247,154 $365 Million
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $22.5 Million - $27.5 Million	189,239 Added 4.38%	4,509,803 $537 Million
Q2 2024 Aug 13, 2024	SELL	$122.71 - $146.91 $103 Million - $123 Million	-840,487 Reduced 16.29%	4,320,564 $617 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $54.5 Million - $72.5 Million	533,716 Added 11.53%	5,161,051 $663 Million
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $30.3 Million - $36.4 Million	345,332 Added 8.06%	4,627,335 $479 Million
Q3 2023 May 14, 2024	SELL	$90.94 - $199.54 $31.4 Million - $68.9 Million	-345,332 Reduced 7.46%	4,282,003 $389 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $220 Million - $484 Million	2,423,736 Added 130.43%	4,282,003 $389 Million
Q2 2023 May 14, 2024	SELL	$155.98 - $172.65 $5.32 Million - $5.88 Million	-34,079 Reduced 1.8%	1,858,267 $301 Million
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $5.32 Million - $5.88 Million	-34,079 Reduced 1.8%	1,858,267 $301 Million
Q1 2023 May 14, 2024	SELL	$132.34 - $159.14 $1.64 Million - $1.97 Million	-12,396 Reduced 0.65%	1,892,346 $301 Million
Q1 2023 May 11, 2023	SELL	$132.34 - $159.14 $1.64 Million - $1.97 Million	-12,396 Reduced 0.65%	1,892,346 $301 Million
Q4 2022 May 14, 2024	BUY	$102.55 - $135.33 $2.05 Million - $2.7 Million	19,969 Added 1.06%	1,904,742 $258 Million
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $2.05 Million - $2.7 Million	19,969 Added 1.06%	1,904,742 $258 Million
Q3 2022 May 14, 2024	BUY	$95.28 - $116.93 $9.35 Million - $11.5 Million	98,129 Added 5.49%	1,884,773 $188 Million
Q3 2022 Nov 10, 2022	BUY	$95.28 - $116.93 $9.35 Million - $11.5 Million	98,129 Added 5.49%	1,884,773 $188 Million
Q2 2022 May 14, 2024	SELL	$103.24 - $121.81 $293 Million - $346 Million	-2,840,691 Reduced 61.39%	1,786,644 $199 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $8.23 Million - $9.71 Million	79,734 Added 4.67%	1,786,644 $199 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $16.4 Million - $19.8 Million	175,732 Added 11.48%	1,706,910 $190 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $11.6 Million - $14.2 Million	-120,913 Reduced 7.32%	1,531,178 $171 Million
Q3 2021 Nov 10, 2021	BUY	$84.42 - $106.62 $139 Million - $176 Million	1,652,091 New	1,652,091 $159 Million

Others Institutions Holding NVO

# of Institutions

1,881

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $199B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Novo Nordisk A S Transaction History